River Vision Development Corp.'s Series B Round

River Vision Development Corp. raised a round of funding on January 07, 2014.

River Vision Development Corp. specializes in the development of teprotumumab, a therapy for an eye condition called Graves' ophthalmopathy.…

Articles about River Vision Development Corp.'s Series B Round: